U.S. Investment in Biotechnology
Author | : United States. Congress. Office of Technology Assessment |
Publisher | : |
Total Pages | : 308 |
Release | : 1988 |
Genre | : Science |
ISBN | : |
Download Us Investment In Biotechnology full books in PDF, epub, and Kindle. Read online free Us Investment In Biotechnology ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads. We cannot guarantee that every ebooks is available!
Author | : United States. Congress. Office of Technology Assessment |
Publisher | : |
Total Pages | : 308 |
Release | : 1988 |
Genre | : Science |
ISBN | : |
Author | : Tang Mark Chilung |
Publisher | : World Scientific |
Total Pages | : 282 |
Release | : 2002-12-02 |
Genre | : Business & Economics |
ISBN | : 9814487643 |
This invaluable book tells the reader how to invest in the healthcare biotechnology and life sciences sector, one of the fast-growing sectors of the US economy. Aimed at biotech investors as well as bioentrepreneurs and venture capitalists, it has been written from the perspectives of risk management and asset management/allocation. It strives to teach readers how to fish, rather than giving them fish. The author has over ten years of Wall Street experience in biotech research, investment banking and asset management. He holds an MBA in Finance and a PhD in Biochemistry.
Author | : National Research Council |
Publisher | : National Academies Press |
Total Pages | : 354 |
Release | : 2001-01-11 |
Genre | : Political Science |
ISBN | : 0309170028 |
This report addresses a topic of recognized policy concern. To capture the benefits of substantial U.S. investments in biomedical R&D, parallel investments in a wide range of seemingly unrelated disciplines are also required. This report summarizes a major conference that reviewed our nation's R&D support for biotechnology and information technologies. The volume includes newly commissioned research and makes recommendations and findings concerning the important relationship between information technologies and biotechnology. It emphasizes the fall off in R&D investments needed to sustain the growth of the U.S. economy and to capitalize on the growing investment in biomedicine. It also encourages greater support for inter-disciplinary training to support new areas such as bioinformatics and urges more emphasis on and support for multi-disciplinary research centers.
Author | : Henri Cartier-Bresson |
Publisher | : |
Total Pages | : 0 |
Release | : 1988 |
Genre | : |
ISBN | : 9780160055331 |
Author | : James D. Mccamant |
Publisher | : Basic Books |
Total Pages | : 208 |
Release | : 2002-06-06 |
Genre | : Business & Economics |
ISBN | : 9780738205090 |
Biotechnology is indisputably one of the fastest-growing and most promising industries. Virtually immune to swings in the economic cycles, biotech stocks continue to perform steadily as high-tech stocks lose their steam.In Biotech Investing, Jim McCamant offers proven strategies and savvy advice on how to capitalize on the unprecedented opportunities in this high-potential sector. Written by a recognized authority, this book dissects biotech business models from start-up to IPO and discusses in detail the most important factors that affect biotech research. Comprehensive in scope, it looks at the best and worst biotech contenders, discusses all the most newsworthy developments in the field, and shows how they translate into business success or failure. It outlines simple criteria for choosing the best biotech stocks and for understanding the sometimes complicated dynamics of this sector.